FDA — authorised 28 March 1980
- Application: NDA018309
- Marketing authorisation holder: TARO
- Local brand name: TOPICORT LP
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Desoximetasone Spray 0.25% in United States
FDA authorised Desoximetasone Spray 0.25% on 28 March 1980
Marketing authorisations
FDA — authorised 1 April 1998
- Application: ANDA073440
- Marketing authorisation holder: ALTANA
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 1 July 2003
- Application: ANDA076510
- Marketing authorisation holder: PADAGIS ISRAEL
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 9 January 2006
- Application: ANDA077552
- Marketing authorisation holder: PADAGIS US
- Local brand name: DESOXIMETASONE
- Indication: GEL — TOPICAL
- Status: approved
FDA — authorised 29 June 2010
- Application: ANDA078369
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 28 September 2012
- Application: ANDA078657
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 20 September 2013
- Application: ANDA202838
- Marketing authorisation holder: GLENMARK PHARMS LTD
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 24 April 2014
- Application: ANDA201005
- Marketing authorisation holder: EPIC PHARMA LLC
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 20 April 2015
- Application: ANDA077770
- Marketing authorisation holder: PADAGIS ISRAEL
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 June 2015
- Application: ANDA203234
- Marketing authorisation holder: SCIEGEN PHARMS
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 4 September 2015
- Application: ANDA205082
- Marketing authorisation holder: ACTAVIS MID ATLANTIC
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 25 February 2016
- Application: ANDA208101
- Marketing authorisation holder: PAI HOLDINGS PHARM
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 10 May 2016
- Application: ANDA206792
- Marketing authorisation holder: NOVEL LABS INC
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 August 2016
- Application: ANDA204675
- Marketing authorisation holder: RISING
- Local brand name: DESOXIMETASONE
- Indication: GEL — TOPICAL
- Status: approved
FDA — authorised 7 November 2016
- Application: ANDA204965
- Marketing authorisation holder: ACTAVIS MID ATLANTIC
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 1 December 2016
- Application: ANDA208104
- Marketing authorisation holder: LUPIN
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 December 2016
- Application: ANDA208044
- Marketing authorisation holder: LUPIN
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 23 December 2016
- Application: ANDA206740
- Marketing authorisation holder: COSETTE
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 6 January 2017
- Application: ANDA203787
- Marketing authorisation holder: SCIEGEN PHARMS
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 20 January 2017
- Application: ANDA206441
- Marketing authorisation holder: PADAGIS ISRAEL
- Local brand name: DESOXIMETASONE
- Indication: SPRAY — TOPICAL
- Status: approved
FDA — authorised 19 September 2017
- Application: ANDA205206
- Marketing authorisation holder: ZYDUS LIFESCIENCES
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 2 July 2018
- Application: ANDA205594
- Marketing authorisation holder: RISING
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 28 September 2018
- Application: ANDA205620
- Marketing authorisation holder: ZYDUS LIFESCIENCES
- Local brand name: DESOXIMETASONE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 23 October 2018
- Application: ANDA209973
- Marketing authorisation holder: THE J MOLNER
- Local brand name: DESOXIMETASONE
- Indication: OINTMENT — TOPICAL
- Status: approved
Other Dermatology approved in United States
Frequently asked questions
Is Desoximetasone Spray 0.25% approved in United States?
Yes. FDA authorised it on 28 March 1980; FDA authorised it on 1 April 1998; FDA authorised it on 1 July 2003.
Who is the marketing authorisation holder for Desoximetasone Spray 0.25% in United States?
TARO holds the US marketing authorisation.